Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Part of paid clinical trials in Houston, Texas.

Sponsor: M.D. Anderson Cancer Center
Study ID: NCT02438904
Status: Recruiting

Apply to this trial

Conditions

Blood And Marrow Transplantation

Eligibility Criteria

Sex: ALL
Age: N/A - N/A
Healthy Volunteers: Not accepted

Interventions

CD34 Positive Stem Cell Infusion — BIOLOGICAL
Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells.
Miltenyi device — DEVICE
Miltenyi device is used for CD34+ cell infusions) to patients who experience poor graft function after stem cell transplantation (SCT).

Study Details

Objectives: Primary Objective To provide compassionate access to the Miltenyi device for CD34+ cell infusions to patients who experience poor graft function after stem cell transplantation (SCT).

Key Dates

Start date: May 6, 2015
Status verified: May 2026
Primary completion: May 1, 2027
Completion: May 1, 2027

Study Design

Enrollment: 200 participants (estimated)
Allocation: NA
Intervention model: SINGLE_GROUP
Primary purpose: OTHER

Arms

Experimental: CD34 Positive Stem Cell Infusion
Participants infused by vein with around 1 - 4 million/kg CD34+ selected cells. If the first infusion is not effective, an additional infusion may be given 4 - 6 weeks after the first infusion.

Primary Outcome Measure

Increased Graft Function after Stem Cell Transplantation (SCT) [ Time Frame: 4 weeks ]

Central Contacts

Elizabeth Shpall, MD
713-745-2161
[email protected]

Locations (1)

Facility	City	State	ZIP	Site coordinators
University of Texas MD Anderson Cancer Center	Houston	Texas	77030	-

Find similar trials in Houston, TX

By research site

University of Texas MD Anderson Cancer Center· Houston, TX